Comparison Chart Avicanna Inc. OTC Markets
Stocks
AVCNF
CA05368K1003
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0959 USD | +27.87% |
|
+7.87% | -40.84% |
| 07-01 | Avicanna Inc. Promotes Nick Hilborn to Chief Financial Officer, Effective June 30, 2026 | CI |
| 05-14 | Avicanna Swings to Net Comprehensive Loss in Q1 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVICANNA INC. | Other Biotechnology & Medical Research | +27.87% | +7.87% | -40.84% | -51.69% | -87.21% | 11.86M |
-
|
-
|
-
|
- Stock Market
- Stocks
- AVCN Stock
- AVCNF Stock
- Charts Avicanna Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
